Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
- PMID: 12912976
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer
Comment on
-
Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.Clin Cancer Res. 2003 Jan;9(1):295-306. Clin Cancer Res. 2003. PMID: 12538482
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical